Semma Therapeutics Overview

  • Founded
  • 2014
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $937M
Latest Deal Amount

Semma Therapeutics General Information

Description

Developer of trans-formative therapies designed to eliminate the use of insulin injections for type 1 diabetes patients. The company's trans-formative therapies is a cell-based therapy for diabetes which traditionally requires the use of an invasive insulin pump or multiple daily insulin injections combining proprietary cells with a state-of-the-art device to provide a replacement for the missing beta cells in a diabetic patient without immunosuppression, enabling doctors to provide a functional cure for patients with diabetes.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
Primary Office
  • 100 Technology Square
  • Floor 3
  • Cambridge, MA 02139
  • United States
+1 (857) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Semma Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 10-Oct-2019 $937M 00000 00000 Completed Generating Revenue
3. Early Stage VC (Series B) 30-Nov-2017 00000 00000 Completed Startup
2. Grant 12-Sep-2016 $5M $44M Completed Startup
1. Early Stage VC (Series A) 24-Mar-2015 $44M $44M 000.00 Completed Startup
To view Semma Therapeutics’s complete valuation and funding history, request access »

Semma Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view Semma Therapeutics’s complete cap table history, request access »

Semma Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of trans-formative therapies designed to eliminate the use of insulin injections for type 1 diabetes patients.
Drug Discovery
Cambridge, MA
00000
0000 0000-00-00
000000&0 00000

00000000

ercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehe
0000000000000
Tucson, AZ
00 As of 0000
000.00
0000 0000-00-00
000000&0 000.00

0000000

fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia de
0000 000000000
San Diego, CA
00 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Semma Therapeutics Competitors (37)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Calimmune Formerly VC-backed Tucson, AZ 00 000.00 000000&0 000.00
0000000 Venture Capital-Backed San Diego, CA 00 00000 000000 - 000 00000
00000000 Venture Capital-Backed South San Francisco, CA 00 00000 0000000000 00000
0000000 Venture Capital-Backed Oslo, Norway 00 0000000000
0000000000 Venture Capital-Backed Abingdon, United Kingdom 000 00000 00000000 00000
You’re viewing 5 of 37 competitors. Get the full list »

Semma Therapeutics Executive Team (15)

Name Title Board Seat Contact Info
Bastiano Sanna Ph.D Chief Executive Officer & President
Mary Fenton Chief Financial Officer
David DiGiusto Ph.D Chief Technical Officer
Briannan Bintz Director of Delivery
Felicia Pagliuca Ph.D Vice President, Cell Biology and Research & Development and Co-Founder
You’re viewing 5 of 15 executive team members. Get the full list »

Semma Therapeutics Former Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
6 Dimensions Capital Venture Capital Minority 000 0000 000000 0
ARCH Venture Partners Venture Capital Minority 000 0000 000000 0
California Institute for Regenerative Medicine Government 000 0000 000000 0
Cowen Healthcare Investments Venture Capital Minority 000 0000 000000 0
Eight Roads Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »

Semma Therapeutics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 16-Nov-2015 000000000000000000 Therapeutic Devices 0000000 000000 00.0
To view Semma Therapeutics’s complete acquisitions history, request access »